Skip to main content
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.10
+0.53 (3.02%)
At close: Nov 4, 2024, 4:00 PM
17.26
-0.84 (-4.64%)
After-hours: Nov 4, 2024, 4:04 PM EST

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $62.90M in the quarter ending September 30, 2024, with 69.56% growth. This brings the company's revenue in the last twelve months to $203.45M, up 57.08% year-over-year. In the year 2023, Travere Therapeutics had annual revenue of $145.24M with 32.69% growth.

Revenue (ttm)
$203.45M
Revenue Growth
+57.08%
P/S Ratio
6.87
Revenue / Employee
$535,387
Employees
380
Market Cap
1.41B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023145.24M35.78M32.69%
Dec 31, 2022109.46M-22.38M-16.97%
Dec 31, 2021131.84M-66.48M-33.52%
Dec 31, 2020198.32M22.98M13.11%
Dec 31, 2019175.34M11.09M6.75%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AMN Healthcare Services 3.23B
Progyny 1.13B
Novavax 987.67M
STAAR Surgical Company 341.22M
Ardelyx 251.85M
Arcus Biosciences 247.00M
Avadel Pharmaceuticals 95.15M
Revenue Rankings

TVTX News

More News